How Big Could Joby Aviation Stock's Next Fall Be?
Joby Aviation (JOBY) stock fell 23.6% in the week to November 16, 2026, trading 71% below its 52-week high. Historically, JOBY has underperformed the S&P 500 during market shocks, with an average decline of 27.1%. Revenue grew to $149 million, but operating loss widened to $979 million. Management expects significant payments and investments in 2027, with a seasonal revenue slowdown in Q4 2026.
How this was made

The 30-second read
Why it matters
For traders, the actionable element is the combination of a specific Q4 revenue guide and quantified 2027 cash outflows and investment inflows that can shift expectations for burn rate, dilution needs, and regulatory/timing risk.
Market read
Joby-specific guidance and quantified 2027 deal and financing items can drive near-term positioning ahead of Q4 and future regulatory milestones.
What to watch
The article focuses on downside scenarios from market shocks; it does not quantify probability of Resonant Sciences approval timing or Toyota investment closing, which could materially change the cash runway narrative.
Background
The piece frames Joby’s drawdowns during prior macro shocks and then ties current risk to management’s latest call, including 2027 payments, Toyota investment, dilution via ATM, and Q4 revenue seasonality.
Ticker impact
Joby guides Q4 Blade revenue to about $17M to $22M and expects $450M Resonant Sciences payments plus Toyota’s $250M investment in 1H 2027.
Likely pressure if investors interpret the Q4 revenue guide and 2027 payment timing as extending losses and cash burn.
The article provides specific management guidance and quantified cash/investment items that directly affect near-term expectations and funding needs.
Market effects
Reinforces risk premium for early-stage eVTOL operators where revenue seasonality, regulatory approvals, and dilution can dominate.
No specific regional market catalyst beyond broad risk sentiment.
Limited, mostly company-specific risk framing for capital-intensive aviation startups.
Counterpoint
The higher full-year revenue guide and rising cash balance could offset near-term caution if Blade demand stabilizes and regulatory approvals arrive on schedule.
Key entities
- companyJoby Aviation
eVTOL operator discussed as the subject of the article, with guidance and financing-related updates.
- counterpartyResonant Sciences
Deal counterparty for which Joby expects about $450M payments early in 2027, subject to approvals and closing conditions.
- counterpartyToyota
Expected to provide a second $250M investment in 1H 2027, subject to closing conditions.




